OpenAlex
PricingAboutJobs
Log inGet started
Work

A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF -mutated and BCL2L1 -amplified Colorectal Cancers

HTML

Year: 2017
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-16-0735
Authors: Sung-Yup Cho, Jee Yun Han, Deukchae Na, Wonyoung Kang, Ahra Lee, Jooyoung Kim, Jieun Lee, Seoyeon Min, Jinjoo Kang, Jeesoo Chae, Jong-Il Kim, Hansoo Park, Won-Suk Lee, Charles Lee
Institutions: Ewha Womans University, Ewha Womans University Mokdong Hospital, Seoul National University, Gwangju Institute of Science and Technology, Gachon University, Gachon University Gil Medical Center, The Jackson Laboratory for Genomic Medicine
Language: English

Topic: Cell death mechanisms and regulation
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: colorectal cancer, KRAS mutation, BRAF mutation, Bcl-xL, Mcl-1, navitoclax, combination therapy, apoptosis inhibition, patient-derived xenografts, anti-EGFR resistance, drug synergy
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: Cancer Center Support (CORE) Grant
OpenAlex ID: W2625289674
FWCI: 1.175
Cites: 50
Cited by: 24
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security